Is Naltrexone the Same as Naloxone? A Clear Guide for Patients and Family Members

They sound identical, but confusing these two medications could be a matter of life or death. When navigating addiction, families constantly ask: Is naltrexone the same as naloxone? One acts as a daily shield for long-term sobriety, while the other is a rapid emergency lifesaver. Uncover the crucial differences in this guide to ensure you know exactly which one to use before it matters most.

Access knowledge via Naloxone Training

TL;DR: 

Naltrexone is a non-addictive medication used to treat opioid and alcohol use disorders by actively blocking the brain’s opioid receptors, which suppresses cravings and neutralizes the euphoric effects of substance use. Available in either a daily oral form or a monthly extended-release injection, the medication is most effective when utilized as part of a comprehensive recovery plan that includes behavioral counseling and peer support. To avoid triggering sudden and severe withdrawal symptoms, patients must be completely opioid-free for 7 to 14 days before initiating treatment.

What is Naltrexone and How does it Work?

Naltrexone is a medication commonly utilized in the treatment of opioid use disorder (OUD) and alcohol use disorder (AUD). It belongs to a class of medications known as opioid antagonists, which means it works by actively blocking opioid receptors in the brain. Unlike opioid medications, naltrexone does not produce euphoric or sedative effects, nor is it considered addictive. It is typically utilized as one component of a broader, comprehensive recovery plan that includes counseling, behavioral therapy, and ongoing medical support.

The medication functions by attaching to opioid receptors without actually activating them. This prevents opioids from producing the pleasurable effects that drive misuse and dependence. National mental health and substance abuse authorities note that naltrexone can effectively reduce cravings and support long-term recovery outcomes. Furthermore, clinical research indicates that when combined with comprehensive care, medications for opioid use disorder improve treatment retention and reduce the risk of overdose.

Naltrexone is also widely used for alcohol dependence. Studies suggest that by blocking opioid pathways, the medication reduces the rewarding sensations associated with alcohol consumption, which helps individuals decrease heavy drinking episodes and maintain sobriety. Because introducing naltrexone while opioids are still in the body can trigger sudden and severe withdrawal symptoms, medical professionals strongly recommend using it under careful supervision, ensuring the patient is completely opioid-free before beginning treatment.

Blocking Opioid Receptors to Prevent Effects

One of naltrexone’s primary functions is its ability to block the brain’s mu-opioid receptors, which are responsible for producing feelings of pain relief and euphoria. If an individual takes opioids while naltrexone is active in their system, the medication prevents those substances from binding effectively to the receptors. As a result, the user does not experience the pleasurable “high” that reinforces continued opioid misuse.

This blocking action is a vital component of relapse prevention. Because the medication interrupts the cycle of reinforcement by neutralizing the euphoric and sedative effects of opioids, individuals recovering from addiction may be less likely to continue using them.

It is important to note that naltrexone differs from medications like methadone or buprenorphine because it blocks opioid activity rather than replacing opioids. Naltrexone does not cause physical dependence, and stopping it does not typically result in withdrawal symptoms. 

Reducing Cravings and Risk of Relapse

Cravings represent one of the most significant challenges in addiction recovery, as the brain continues to associate substances with pleasure and emotional relief. Naltrexone is frequently used to suppress these cravings and lower the risk of relapse. By blocking opioid receptors, it reduces the rewarding sensations tied to substance use, helping to decrease the urge to use again.

Public health and substance abuse authorities view naltrexone as a valuable tool for individuals who have completed detoxification and are committed to maintaining their recovery. Healthcare providers frequently incorporate it into long-term relapse prevention plans because combining medication-assisted treatment with behavioral support tends to decrease relapse rates.

• Overdose Vulnerability: Relapse prevention is particularly critical because patients who discontinue naltrexone and return to opioid use are highly vulnerable to overdose. This heightened risk occurs because the body’s opioid tolerance significantly drops during a period of abstinence.
• Improving Engagement: To improve treatment engagement, recent federally supported clinical trials have explored faster initiation protocols for extended-release injectable naltrexone, demonstrating ongoing efforts to make recovery treatments more accessible and effective.

Supporting Long-Term Recovery Treatment

Addiction is a chronic medical condition that often involves periods of relapse and recovery, meaning long-term success requires more than just short-term detoxification. Naltrexone is commonly integrated into a “whole-patient approach” designed to address both the psychological and physical aspects of addiction. This helps individuals maintain abstinence while they actively develop healthier coping strategies and lifestyle changes.

Healthcare professionals frequently pair naltrexone with mental health services, peer support, and family counseling. This integrated model helps individuals rebuild their routines, relationships, and emotional stability. Research shows that medication-based approaches for opioid use disorder can reduce overdose deaths, improve treatment retention, decrease behaviors linked to infectious disease transmission, and support overall quality of life, including employment and family functioning.

Administering Oral or Injectable Forms

Naltrexone is available in two formulations, allowing providers to tailor the treatment to a patient’s specific recovery goals. The choice between oral and injectable forms is based on the patient’s medical history, access to treatment, and personal preference. Recent clinical studies also suggest that accelerating the initiation of the injectable form (beginning within five to seven days of seeking care) may improve treatment success compared to longer waiting periods, though it requires enhanced medical oversight.

Monitoring Use Under Medical Supervision 

Given the risks associated with early initiation, medical supervision is a critical component of naltrexone treatment. Before starting, patients undergo an evaluation—which may include urine drug screenings or a naloxone challenge test—to confirm that their body is completely free of opioids.

General health guidelines advise waiting at least seven days after using short-acting opioids, and up to 10 to 14 days after using long-acting opioids, before taking naltrexone. Starting too soon can trigger severe withdrawal symptoms requiring immediate medical intervention.

Ongoing monitoring allows healthcare teams to manage side effects, track recovery progress, and monitor liver function and mental health. A vital part of this supervision involves educating patients about their lost opioid tolerance and the severe overdose risk if they relapse after stopping the medication. By addressing the individual’s overall physical, social, and emotional needs through continuous monitoring and coordinated counseling, healthcare providers can greatly reduce the likelihood of future relapse and support lasting recovery.

Key Takeaways:

1. Mechanism of Action and Cravings: Naltrexone is a non-addictive medication used to treat opioid and alcohol use disorders by actively blocking the brain’s mu-opioid receptors. By neutralizing the euphoric and sedative effects of these substances, it effectively suppresses intense cravings and interrupts the cycle of reinforcement to prevent relapse.
2. The Necessity of Prior Detoxification: Patients must be completely opioid-free for 7 to 14 days before beginning naltrexone, as starting the medication too early can trigger sudden, severe withdrawal symptoms. Because of this inherent biological risk, initiating the treatment requires strict medical supervision and pre-evaluations like urine screenings.
3. Integrated Long-Term Recovery: Addiction is a chronic condition that requires a “whole-patient approach,” meaning naltrexone is most effective when combined with comprehensive behavioral support. Pairing the medication with mental health services, peer support, and family counseling helps individuals maintain abstinence while rebuilding their routines and emotional stability.
4. Adaptable Administration Options: Treatment can be tailored to a patient’s needs through either a daily oral pill or a monthly extended-release injection. While the daily oral form requires strict adherence to remain effective, the injectable option removes daily dosing decisions and significantly improves overall treatment consistency.
5. Overdose Vulnerability and Monitoring: Continuous medical supervision is crucial to manage side effects, track progress, and educate patients on their significantly lowered opioid tolerance during recovery. This education is a matter of life or death, as relapsing after a period of naltrexone-assisted abstinence carries a severely heightened risk of fatal overdose.

FAQs: 

What is naltrexone? 

Naltrexone is a non-addictive medication commonly utilized to treat opioid use disorder (OUD) and alcohol use disorder (AUD). As an opioid antagonist, it works by actively attaching to and blocking opioid receptors in the brain, effectively preventing substances from producing the pleasurable, euphoric, or sedative effects that drive misuse.

What is the difference between naloxone and naltrexone? 

While their names sound identical, confusing the two can be a matter of life or death because they serve entirely different roles in addiction management. The text distinguishes them by noting that one medication acts as a daily shield to help maintain long-term sobriety, while the other is utilized as a rapid emergency lifesaver.

What is naloxone? 

Naloxone is a medication utilized as a rapid emergency lifesaver. Additionally, healthcare providers use it in a “naloxone challenge test” during a patient’s initial evaluation to confirm that their body is completely free of opioids before they begin other treatments.

What are naloxone and naltrexone used for? 

Naltrexone is used to treat opioid use disorder (OUD) and alcohol use disorder (AUD) by acting as a daily shield to support long-term sobriety. It works by actively blocking opioid receptors in the brain to reduce cravings and prevent the pleasurable effects that drive misuse. In contrast, naloxone is used as a rapid emergency lifesaver and is also administered in clinical challenge tests to ensure a patient is entirely opioid-free before starting naltrexone therapy.

Sources. 

National Institutes of Health. (2024, March 22). Faster approach for starting extended-release naltrexone to treat opioid use disorder shown effective. U.S. Department of Health and Human Services. https://www.nih.gov/news-events/news-releases/faster-approach-starting-extended-release-naltrexone-treat-opioid-use-disorder-shown-effective 

Centers for Disease Control and Prevention. (2024, May 15). Recovery is possible: Treatment for opioid addiction. U.S. Department of Health and Human Services. CDC Overdose Prevention Page

You May Also Like: 

Can You Overdose on Narcan? Risks and Facts Explained

Is Naloxone Safe in Pregnancy? What You Need to Know

substance use disorder education and treatment